Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study

Bibliographic Information
Authors: Fayed A.; Hammad A.A.; Abdulazim D.O.; Hammad H.; Amin M.; Elhadidy S.; Salem M.M.; ElAzim I.M.A.; Zsom L.; Csongradi E.; Soliman K.M.; Sharaf El Din U.A.
Journal: Renal Failure
Publisher: Taylor and Francis Ltd.
Publication Date: 28 March 2023
Volume / Issue: Volume 45 / Issue 1
Article No.: 2194434
ISSN: 0886022X
DOI: 10.1080/0886022X.2023.2194434
Scopus: View on Scopus
PubMed: 36974638
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Fayed A., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt; Hammad A.A., Endocrinology Unit, Internal Medicine Department, Faculty of Medicine, Fayoum University, Faiyum, Egypt; Abdulazim D.O., Rheumatology and Rehabilitation Department, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt; Hammad H., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt; Amin M., Critical Care Medicine Department, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt; Elhadidy S., Critical Care Medicine Department, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt; Salem M.M., Endocrinology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt; ElAzim I.M.A., Critical Care Medicine, Theodor Bilharz Research Institute, Cairo, Egypt; Zsom L., Fresenius Medical Care Hungary, Cegléd, Hungary; Csongradi E., Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; Soliman K.M., Department of Surgery, Division of Transplant, Medical University of South Carolina, Charleston, SC, United States; Sharaf El Din U.A., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt
Abstract
Background: Patients with diabetic kidney disease (DKD) are at increased risk to develop post-contrast acute kidney injury (AKI). Diabetic patients under dipeptidyl peptidase 4 inhibitors (DPP4Is) experience a lower propensity to develop AKI. We speculated that linagliptin as a single agent or in combination with allopurinol may reduce the incidence of post-contrast AKI in stage 3–5 chronic kidney disease (CKD) patients with underlying DKD. Methods: Out of 951 DKD patients eligible for this study, 800 accepted to sign informed consent. They were randomly allocated to 4 equal groups that received their prophylaxis for 2 days before and after radiocontrast. The first control group received N-acetyl cysteine and saline, the 2nd received allopurinol, the 3rd group received linagliptin, and the 4th received both allopurinol and linagliptin. Post-procedure follow-up for kidney functions was conducted for 2 weeks in all patients. Results: 20, 19, 14, and 8 patients developed post-contrast AKI in groups 1 through 4, respectively. Neither linagliptin nor allopurinol was superior to N-acetyl cysteine and saline alone. However, the combination of the two agents provided statistically significant renal protection: post-contrast AKI in group 4 was significantly lower than in groups 1 and 2 (p < 0.02 and <0.03, respectively). None of the post-contrast AKI cases required dialysis. Conclusion: Linagliptin and allopurinol in combination may offer protection against post-contrast AKI in DKD exposed to radiocontrast. Further studies are needed to support this view. Trial registration ClinicalTrials.gov: NCT03470454. © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Keywords
allopurinol; DPP4Is; linagliptin; N-acetyl cysteine; Post-contrast AKI; Acute Kidney Injury; Cysteine; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Prospective Studies; Renal Insufficiency, Chronic; acetylcysteine; creatinine; hemoglobin A1c; iohexol; iopromide; sodium chloride; urea; uric acid; acute kidney failure; adult; albumin to creatinine ratio; Article; body mass; chronic kidney failure; clinical feature; contrast induced nephropathy; controlled study; coronary angiography; creatinine blood level; cross-sectional study; diabetic nephropathy; disease duration; estimated glomerular filtration rate; female; follow up; glomerulus filtration rate; human; kidney function; kidney function test; major clinical study; male; middle aged; multicenter study; observational study; prophylaxis; prospective study; randomized controlled trial; renal protection; urea blood level; urea nitrogen blood level; clinical trial
Citation Information
Scopus Citations: 1
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
